Tue, Sep 23, 2014, 12:48 AM EDT - U.S. Markets open in 8 hrs 42 mins

Recent

% | $
Quotes you view appear here for quick access.

Seattle Genetics Inc. Message Board

  • ricardouno ricardouno Apr 4, 2014 2:08 PM Flag

    The Intersection

    The long term prospects for this Company have never seemed better.......marketed product, clinical pipeline, finances, licensed technology. A level of desirability and usefulness from drugs that save and change lives and not primarily just small incremental improvements.

    The shorter term sentiment in the Market for Biotechs has seldom been worse.

    At some point an intersection will be met when consideration of the above two issues will create a revelation and the price will stabilize...... and market manipulation will cease in favor of a re-established and well grounded investment thesis.

    Have we reached that point? Who knows!?

    Good luck to all,

    Ricardo

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Biotech stocks has been brutal since early March. Most always market over and undershoot by big percentages. Unless you have to sell because you need the money, nothing has changed with regards to the company's operation and prospects except that the conclusion of ongoing trials is now that much closer and with each day that goes by the odds of positive results increases. I'm not saying that the share price free fall is not bothersome but I'm not a trader and this has happened here many time and on regular bases. As always, my biggest concern during these dives is that a rapacious BP swoons in and snatches the company at a big discount. The only thing that may stand in the way of that happening are the BB so it is a pretty good barrier but with biotech caught in a death spiral as it currently looks like, an extended duration could trip even them and force their hand. Having said that and given that BB know science as well as any other, that would have to be the nuclear option for them and I don't see it happening. With updates on front line trials due shortly (July?) and the over 60 in particular (Can't remember the official name for it still) I'm expecting the reversal and ascension to be even faster than the dive. There are a few weeks before the next Q1 CC and SGEN must be in the quiet period which is providing relative safety for the "sellers".
      We'll see

    • Good summary. And yet for all its positive attributes, SGEN has consistently been one of the weakest stocks out there.

    • been a rough ride

 
SGEN
40.03-0.57(-1.40%)Sep 22 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.